BIM
AVNR

BlackRock Investment Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

BlackRock Investment Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-555,479
Closed -$9.41M – 4201
2014
Q4 		$9.41M Buy
555,479
+58,162
+12% +$818K 0.01% 978
2014
Q3 		$5.93M Buy
497,317
+32,945
+7% +$225K 0.01% 1224
2014
Q2 		$2.62M Buy
464,372
+62,368
+16% +$287K ﹤0.01% 1867
2014
Q1 		$1.48M Buy
402,004
+2,921
+0.7% +$11.1K ﹤0.01% 2244
2013
Q4 		$1.34M Sell
399,083
-12,655
-3% -$52.3K ﹤0.01% 2295
2013
Q3 		$1.74M Buy
411,738
+25,927
+7% +$123K ﹤0.01% 2050
2013
Q2 		$1.77M Buy
+385,811
New +$1.33M ﹤0.01% 1936

BlackRock Investment Management's AVNR Position: Q1 2015 in Review

BlackRock Investment Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 555,479 shares — an estimated $9.41M sold.

BlackRock Investment Management first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $9.41M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • BlackRock Investment Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 555,479 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $9.41M.
  • BlackRock Investment Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • BlackRock Investment Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $9.41M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on BlackRock Investment Management's 13F filing for Q1 2015, filed 13 May 2015.